Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V N Protasov

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Voenno-Meditsinskii Zhurnal|August 1, 1973
[Physiological and hygienic research under unit conditions]V N Protasov
Voenno-Meditsinskii Zhurnal|November 1, 1972
[Industrial hygiene in outdoor and indoor repair shops (guide for the young doctor)]V N Protasov
Voenno-Meditsinskii Zhurnal|February 1, 1984
[Methods of preventing overfatigue (a review of the literature)]V N Protasov
Kardiologiia|June 9, 2015
[The role of markers of organ damage in patients with chronic heart failure]L E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 21, 2014
[Treatment of patients with chronic heart failure based on monitoring of concentrations of natriuretic peptides--to what extent it is justified in clinical practice?]A A Skvortsov, D E Koshkina, O Iu Narusov, et al.
Kardiologiia|March 16, 2017
[The Role of Markers of Organ Damage in Patients With Chronic Heart Failure]D E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 15, 2017
[Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results]A A Skvortsov, D E Koshkina, O Yu Narusov, et al.
Kardiologiia|March 15, 2017
[Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation]A A Skvortsov, V N Protasov, O Yu Narusov, et al.
Kardiologiia|January 10, 2019
A A Skvortsov, O Yu Narusov, M D Muksinova, et al.
Kardiologiia|February 22, 2018
[Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation]O Y Narusov, D E Koshkina, V N Protasov, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Voenno-Meditsinskii Zhurnal|August 1, 1973
[Physiological and hygienic research under unit conditions]V N Protasov
Voenno-Meditsinskii Zhurnal|November 1, 1972
[Industrial hygiene in outdoor and indoor repair shops (guide for the young doctor)]V N Protasov
Voenno-Meditsinskii Zhurnal|February 1, 1984
[Methods of preventing overfatigue (a review of the literature)]V N Protasov
Kardiologiia|June 9, 2015
[The role of markers of organ damage in patients with chronic heart failure]L E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 21, 2014
[Treatment of patients with chronic heart failure based on monitoring of concentrations of natriuretic peptides--to what extent it is justified in clinical practice?]A A Skvortsov, D E Koshkina, O Iu Narusov, et al.
Kardiologiia|March 16, 2017
[The Role of Markers of Organ Damage in Patients With Chronic Heart Failure]D E Koshkina, A A Skvortsov, V N Protasov, et al.
Kardiologiia|March 15, 2017
[Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results]A A Skvortsov, D E Koshkina, O Yu Narusov, et al.
Kardiologiia|March 15, 2017
[Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation]A A Skvortsov, V N Protasov, O Yu Narusov, et al.
Kardiologiia|January 10, 2019
A A Skvortsov, O Yu Narusov, M D Muksinova, et al.
Kardiologiia|February 22, 2018
[Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation]O Y Narusov, D E Koshkina, V N Protasov, et al.
Pageof 2